Fraunhofer ITEM: expertisecentrum voor Translationele Biomedische Technologie geopend
HANNOVER, Duitsland–(BUSINESS WIRE)–Dr. Gabriele Heinen-Kljajić, minister van Wetenschap en Cultuur van Nedersaksen, en hoogleraar Reimund Neugebauer, voorzitter van het Fraunhofer-Gesellschaft, hebben op 25 april samen met vertegenwoordigers uit de sector, van de overheid en de academische wereld het expertisecentrum voor Translationele Biomedische Technologie in Hannover geopend.
Het centrum is opgericht om medische hulpmiddelen van het laboratorium de eerste fase van klinische ontwikkeling in te loodsen. De focus ligt bij actieve implantaten en technologische oplossingen voor medicijntoediening via inademing. Die laatste categorie wordt systematisch doorontwikkeld in producten die intelligente geneesmiddelen en apparaten combineren. Het centrum wordt gefinancierd door de Nedersaksische overheid en het Fraunhofer-Gesellschaft.
Fraunhofer ITEM: High-Performance-Center Translational Medical Engineering |
|||||
|
HANNOVER, Germany–(BUSINESS WIRE)– Together with representatives from industry, government and academia, Dr. Gabriele Heinen-Kljajić, Minister for Science and Culture of Lower Saxony, and Prof. Reimund Neugebauer, President of the Fraunhofer-Gesellschaft inaugurated the High-Performance Center Translational Biomedical Engineering in Hannover on April 25. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170425006452/en/  Representatives from industry, government and academia have opened the High-Performance Center Translational Medical Engineering: (from left to right) Dr. Gabriele Heinen-Kljajić, Minister for Science and Culture of Lower Saxony, Prof. Theodor Doll, Head of the High-Performance Center, Prof. Norbert Krug, Director of Fraunhofer ITEM, Prof. Reimund Neugebauer, President of the Fraunhofer-Gesellschaft, Prof. Christopher Baum, President of the Hannover Medical School, and Prof. Thomas Lenarz, Professor and Chairman of the Department of Otorhinolaryngology of the Hannover Medical School (sitting at the front). (Photo: Business Wire)
The Center is aimed at bringing medical devices from the lab into phase I of clinical development. The focus is on active implants and technological solutions for inhaled drug delivery. The latter are systematically developed towards smart-drug/device combination products. The Center is funded by the Lower-Saxony government and the Fraunhofer-Gesellschaft. “Be it research on and development of implants, regenerative or personalized medicine – we want to contribute to overcoming the difficult step of transferring medical research results into clinical application, so that patients can benefit from novel products and methods. The new High-Performance Center Translational Biomedical Engineering provides a valuable link between research institutions and industry. It further strengthens the close network of research in the life sciences in Hannover,” said Heinen-Kljajić. “In this Center, we will assist researchers, companies and entrepreneurs from the very phase of development. Dedicated manufacturing processes, for example, commonly represent substantial economic hurdles for small and medium-sized enterprises. Furthermore, medical devices equally have to go through quality assurance and risk assessment processes, before they can progress to clinical trials. We guide through the sophisticated processes of bringing devices from basic research to clinical application,” said Prof. Theodor Doll, head of the Center. Doll is holding a professorship instituted at the Hannover Medical School in collaboration with Fraunhofer ITEM. It directly connects the research done in the clusters of excellence REBIRTH and “ Hearing4all” in Hannover and in the Lower-Saxony consortium “ Biofabrication for NIFE” with the Fraunhofer ITEM translation expertise. “Within a very short time, the High-Performance Centers of the Fraunhofer-Gesellschaft have proven to excellently support cooperation with universities and industry. The aim is to broadly promote research and education, training and continuing professional development, career opportunities for both young and senior scientists, and the transfer from lab to fab. The High-Performance Centers shall be established as infrastructure for this transfer,” explained Neugebauer. “The new Translational Biomedical Engineering Center provides optimal opportunities to step into a top position in innovative medical device development. Together with our partners, we can provide decisive impetus for future innovations to industry, SMEs and start-ups in the medical sector.” Further information: https://www.item.fraunhofer.de/en/press-and-media/press-releases/PM_center_inauguration.html. View source version on businesswire.com: http://www.businesswire.com/news/home/20170425006452/en/ Contacts Fraunhofer ITEM |
|||||